Home
>
National Drug Code (NDC)
>
KADCYLA
KADCYLA - 50242-087-01 - (ADO-TRASTUZUMAB EMTANSINE)
Drug Information of KADCYLA
| Product NDC: | 50242-087 |
| Proprietary Name: | KADCYLA |
| Non Proprietary Name: | ADO-TRASTUZUMAB EMTANSINE |
| Active Ingredient(s): | 20 mg/mL & nbsp; ADO-TRASTUZUMAB EMTANSINE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of KADCYLA
| Product NDC: | 50242-087 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125427 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20130222 |
Package Information of KADCYLA
| Package NDC: | 50242-087-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (50242-087-01) > 8 mL in 1 VIAL, SINGLE-USE |
NDC Information of KADCYLA
| NDC Code | 50242-087-01 |
| Proprietary Name | KADCYLA |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (50242-087-01) > 8 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 50242-087 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ADO-TRASTUZUMAB EMTANSINE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130222 |
| Marketing Category Name | BLA |
| Labeler Name | Genentech, Inc. |
| Substance Name | ADO-TRASTUZUMAB EMTANSINE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
